Abstract
Infections with Candida albicans are associated with a depressed immune response. The immunological profile present during candidiasis is extremely complex. Certain individuals with a congenital defect in the development of a normal cellular immune system are frequently the subject of clinical Candida disease involving mucocutaneous tissues (reviewed in 1). On the other hand, disseminated candidiasis is frequently encountered in individuals suffering with polymorphonuclear leukocyte function such as chronic granulomatous disease, myeloperoxidase deficiency, or Chediak-Higashi Syndrome (2,3,4). Individuals who manifest both mucocutaneous and disseminated forms of candidiasis are rare. The mode of resistance against these two forms of candidiasis presents a paradox since immune mechanisms effective in the first case apparently do not operate in the other.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Rogers, T. J., and E. Balish. 1980. Immunity to Candida albicans. Microbiol. Rev. 44: 660–682.
Lehrer, R. I. 1970. Measurement of candidacidal activity of specific leukocyte types in mixed cell populations. I. Normal myeloperoxidase deficient, and chronic granulomatous disease neutrophils. Infect. Immun. 2: 42–47.
Lehrer, R. I. 1971. Measurement of candidacidal activity of specific leukocyte types in mixed cell poulations. H. Normal and chronic granulomatous disease eosinophils. Infect. Immun. 3: 800–802.
Anderson, W. D. 1971. Pathology. C. V. Mosby Co., St. Louis.
Valdimarsson, H., J. Higgs, R. Wells, M. Yamamura, J. Hobbs, and P. Holt. 1973. Immune abnormalities associated with chronic mucocutaneous candidiasis. Cell. Immunol. 11: 348–361.
Paterson, P., R. Semo, B. Blumenschein, and J. Swetlstad. 1971. Mucocutaneous anergy and a plasma inhibitor of cellular immunity: reversal after amphotericin B therapy. Clin. Exp. Immunol. 9: 595–602.
Kirkpatrick, C., R. Rich, and J. Bennett. 1971. Chronic mucocutaneous candidiasis: model-building in cellular immmunity. Ann. Intern. Med. 74: 955–978.
Budtz-Jorgensen, E. 1973. Cellular immunity in acquired candidiasis of the palate. Scand. J. Dent. Res. 81: 372–382.
Fischer, G., and L. Horbach. 1958. Untersuchungen uber Promunitat und Infektionsimmunitat bei der experimentallen Soorinfektion. Arch. Hyg. Bakteriol. 142: 14–25.
Mankiewicz, E., E. Stackiewicz, and M. Liivak. 1959. A polysaccharide isolated f om Candida albicans as a growth promoting factor for tuberculosis. Can. J. Microbiol. 5: 261–267.
Mankiewicz, E., and M. Liivak. 1960. Effect of Candida albicans on the evolution of experimental tuberculosis. Nature (London) 187: 250251.
Ferrante, A., and T. H. Thong. 1980. The effect of amphotericin B treatment on Candida albicans-induced imunosuppression in mice. Immunol. Lett. 1: 321–323.
Vardinon, N., and E. Segal. 1979. Suppressive action of Candida albicans on the immune system in mice. Exp. Cell. Biol. 47: 275–280.
Rogers, T., and E. Balish. 1978. Suppression of lymphocyte blastogenesis by Candida albicans. Clin. Immunol. Immunopathol. 10: 298305.
Rivas, V. and T. Rogers. 1983. Studies on the nature of albicans-induced suppression. Candida J. Immunol. 130: 376–379.
Cuff, C., C. Rogers, B. Lamb, suppressor cells in vitro by and T. Rogers. 1986. Induction of Candida albicans. Cell. Immunol. 100: 47–56.
Bruce, J. F. Symington, T. McKearn, and J. Sprent. 1981. A monoclonal antibody discriminating between subsets of T and B cells. J. Immunol. 127: 2496–2501.
Raychaudhuri, S., and M. Cancro. 1985. Cellular basis for neonatally induced T-suppressor activity. J. Exp. Med. 161: 816–829.
Smith, H., L. Jaffe, D. Kastner, and A. Steinberg. 1986. Evidence that Lyb-5 is a differentiation antigen in normal and xid mice. J. Immunol. 136: 1194–1200.
Piccolella, E., G. Lombardi, and R. Morelli. 1981. Generation of suppressor cells in the response of human lymphocytes to a polysaccharide from Candida albicans. J. Immunol. 126: 2151–2155.
Picolella, E., G. Lombardi, and R. Morelli. 1981. Mitogenic response of human peripheral blood lymphocytes to a purified C. albicans polysaccharide fraction: lack of helper activities is responsible for the in vitro unresponsiveness to a second antigenic challenge. J. Immunol. 126: 2156–2160.
Lombardi, G., D. Vismara, E. Picolella, V. Colizzi, and G. Asherson. 1985. Non-specific inhibitor produced by Candida albicans activated T-cells impairs cell proliferation by inhibiting interleukin-1 production. Clin. Exp. Immunol. 60: 303–310.
Mond, J., J. Farrar, W. Paul, J. Fuller-Farrar, M. Schaefer, and M. Howard. 1983. T-cell dependence and factor reconstitution of in vitro antibody responses to TNP-B. abortus and TNP-Ficoll: restoration of depleted responses with chromatographed fractions of a T-cell-derived factor. J. Immunol. 131: 633–637.
Mathur, S., J. Melchers III, E. Ades, H. Williamson, and H. Fudenberg. 1980. Anti-ovarian and anti-lymphocyte antibodies in patients with chronic vaginal candidiasis. J. Reprod. Immunol. 2: 247–262.
Fischer, A., J. Ballet, and C. Griscelli. 1978. Specific inhibition of in vitro Candida-induced lymphocyte proliferation by polysaccharide antigens present in the serum of patients with chronic mucocutaneous candidiasis. J. Clin. Invest. 62: 1005–1013.
Fischer, A., L. Pichat, M. Audinot, and C. Griscelli. 1982. Defective handling of mannan by monocytes in patients with chronic mucocutaneous candidiasis resulting in a specific cellular unresponsiveness. Clin. Exp. Immunol. 47: 653–660.
Piccolella, E., G. Lombardi, and R. Morelli. 1980. Human lymphocyte activating properties of a purified polysaccharide from Candida albicans: B and T cell cooperation in the mitogenic response. J. Immunol. 125: 2082–2088.
Carrow, E., and J. Domer. 1985. Immunoregulation in experimental murine candidiasis:specific suppression induced by Candida albicans cell wall glycoprotein. Infect. Immun. 49: 172–181.
Cassone, A., P. Marconi, F. Bistoni, E. Mattia, G. Sbaraglia, E. Garaci, and E. Bonmassar. 1981. Immunoadjuvant effects of Candida albicans and its cell wall fractions in a mouse lymphoma model. Clin. Immunol. Immunother. 10: 181–190.
Smail, E. and J. Jones. 1984. Demonstration and solubilization of antigens expressed primarily on the surfaces of Candida albicans germ tubes. Infect. Immun. 45: 74–81.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer Science+Business Media New York
About this chapter
Cite this chapter
Cuff, C.F. et al. (1988). Induction of Immunosuppressive B-Lymphocytes with Components of Candida Albicans . In: Eisenstein, T.K., Bullock, W.E., Hanna, N. (eds) Host Defenses and Immunomodulation to Intracellular Pathogens. Advances in Experimental Medicine and Biology, vol 239. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-5421-6_35
Download citation
DOI: https://doi.org/10.1007/978-1-4757-5421-6_35
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-5423-0
Online ISBN: 978-1-4757-5421-6
eBook Packages: Springer Book Archive